Secretory leukocyte protease inhibitor (SLPI), a multifunctional protein in the host defense response

Cytokine Growth Factor Rev. 2016 Apr:28:79-93. doi: 10.1016/j.cytogfr.2015.12.001. Epub 2015 Dec 15.

Abstract

Secretory leukocyte protease inhibitor (SLPI), a ∼12kDa nonglycosylated cationic protein, is emerging as an important regulator of innate and adaptive immunity and as a component of tissue regenerative programs. First described as an inhibitor of serine proteases such as neutrophil elastase, this protein is increasingly recognized as a molecule that benefits the host via its anti-proteolytic, anti-microbial and immunomodulatory activities. Here, we discuss the diverse functions of SLPI. Moreover, we review several novel layers of SLPI-mediated control that protect the host from excessive/dysregulated inflammation typical of infectious, allergic and autoinflammatory diseases and that support healing responses through affecting cell proliferation, differentiation and apoptosis.

Keywords: Allergy; Autoimmunity; Elastase; Inflammation; Protease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Autoimmunity / immunology
  • Humans
  • Leukocyte Elastase / immunology
  • Leukocyte Elastase / metabolism
  • Secretory Leukocyte Peptidase Inhibitor / immunology*
  • Secretory Leukocyte Peptidase Inhibitor / metabolism*
  • Wound Healing / physiology

Substances

  • SLPI protein, human
  • Secretory Leukocyte Peptidase Inhibitor
  • Leukocyte Elastase